Overview
Pavani Chalasani is a Hematologist Oncology specialist and a Hematologist in Washington, Washington, D.c.. Dr. Chalasani is rated as an Experienced provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, and Paget Disease of the Breast. Dr. Chalasani is currently accepting new patients.
Her clinical research consists of co-authoring 54 peer reviewed articles and participating in 23 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Pancreatic Ductal Adenocarcinoma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2150 Pennsylvania Ave Nw, Washington, DC 20037
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
23 Clinical Trials
Elizabeth Jaffee is an Oncologist in Baltimore, Maryland. Dr. Jaffee is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. Her top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Fibrolamellar Carcinoma, Pancreaticoduodenectomy, and Hepato-Pancreato-Biliary Surgery.
Skip Viragh Outpatient Cancer Center
Dr. Daniel Laheru is a cancer specialist in Baltimore, caring for patients with pancreatic cancer, colorectal cancer and neuroendocrine cancers. Dr. Laheru serves as co-director of the Skip Viragh Center for Pancreas Cancer Clinical Research and Patient Care at Johns Hopkins Medicine. Dr. Laheru received his undergraduate degree in chemistry from The University of Utah. He earned his M.D. at Baylor College of Medicine. He completed his residency at The University of Utah Hospital and Clinics and performed a fellowship in medical oncology at The Johns Hopkins University School of Medicine and The Johns Hopkins Oncology Center. Dr. Laheru joined the Johns Hopkins faculty in 2001. Dr. Laheru's research interests include pancreatic cancer and chemotherapy resistance in pancreatic cancer. With Elizabeth Jaffee, M.D., he developed a vaccine that supercharges the immune system and causes immune cells, which tend to be tolerant of cancer, to seek out and kill pancreatic cancer cells throughout the body. He has given numerous invited talks on pancreatic cancer and other cancers both nationally and internationally. He has authored over 200 papers focused on pancreatic cancer. Dr. Laheru serves as associate editor of Annals of Pancreatic Cancer. He has been recognized by the American Society of Clinical Oncology with the Young Investigator Award, by the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins as an Isaac and Catharine Hecht Scholar and has been elected to the Miller-Coulson Academy of Clinical Excellence. He is a member of the American College of Physicians, the American Society of Clinical Oncology and the American Association for Cancer Research. Dr. Laheru is rated as an Elite provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy.
Medstar Medical Group Ii LLC
Benjamin Weinberg is a Hematologist Oncology specialist and a Hematologist in Washington, Washington, D.c.. Dr. Weinberg is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. His top areas of expertise are Colorectal Cancer, Pancreatic Cancer, Familial Colorectal Cancer, Vertebroplasty, and Colonoscopy. Dr. Weinberg is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Breast CancerDr. Chalasani isElite. Learn about Breast Cancer.
- Distinguished
- AngiosarcomaDr. Chalasani isDistinguished. Learn about Angiosarcoma.
- Inflammatory Breast CancerDr. Chalasani isDistinguished. Learn about Inflammatory Breast Cancer.
- Paget Disease of the BreastDr. Chalasani isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- Breast Cancer in MenDr. Chalasani isAdvanced. Learn about Breast Cancer in Men.
- Familial Prostate CancerDr. Chalasani isAdvanced. Learn about Familial Prostate Cancer.
- Intraductal PapillomaDr. Chalasani isAdvanced. Learn about Intraductal Papilloma.
- Prostate CancerDr. Chalasani isAdvanced. Learn about Prostate Cancer.
- Experienced
- Acquired HemophiliaDr. Chalasani isExperienced. Learn about Acquired Hemophilia.
- Acute Lymphoblastic Leukemia (ALL)Dr. Chalasani isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Adult Immune ThrombocytopeniaDr. Chalasani isExperienced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Chalasani isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Chalasani isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Chalasani isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.

